ME — 23andMe Holding Co. Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for 23andMe Holding Co., fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	208	282	553	387	216
Net Total Accounts Receivable
Net Total Receivables	6.39	2.48	3.38	1.9	9.07
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	253	314	602	425	255
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	138	124	105	94.7	77.2
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	405	452	1,152	943	395
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	139	122	153	149	127
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	270	210	236	229	207
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	134	242	916	714	189
Total Liabilities & Shareholders' Equity	405	452	1,152	943	395
Total Common Shares Outstanding
Total Preferred Shares Outstanding